EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles

Meina Zhu, Zhaohui Lan, Joohyun Park, Shuaishuai Gong, Yan Wang, Fuzheng Guo iD

Neuropathology and Applied Neurobiology · 2024-04 · 50 (2)

DOI: 10.1111/nan.12980 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuropathology and Applied Neurobiology, online erschienen am 22.04.2024. Verfasst von Meina Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, UC Davis School of Medicine, Institute for Pediatric Regenerative Medicine (IPRM), Shriners Hospitals for Children, Sacramen…. Hauptthemen laut MEDLINE: Serpins. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, National Institute of Neurological Disorders and Stroke, Shriners Hospitals for Children.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroinflammation, blood–brain barrier (BBB) dysfunction, neuron and glia injury/death and myelin damage are common central nervous system (CNS) pathologies observed in various neurological diseases and injuries. Serine protease inhibitor (Serpin) clade A member 3n (Serpina3n), and its human orthologue SERPINA3, is an acute‐phase inflammatory glycoprotein secreted primarily by the liver into the bloodstream in response to systemic inflammation. Clinically, SERPINA3 is dysregulated in brain cells, cerebrospinal fluid and plasma in various neurological conditions. Although it has been widely accepted that Serpina3n/SERPINA3 is a reliable biomarker of reactive astrocytes in diseased CNS, recent data have challenged this well‐cited concept, suggesting instead that oligodendrocytes and neurons are the primary sources of Serpina3n/SERPINA3. The debate continues regarding whether Serpina3n/SERPINA3 induction represents a pathogenic or a protective mechanism. Here, we propose possible interpretations for previously controversial data and present perspectives regarding the potential role of Serpina3n/SERPINA3 in CNS pathologies, including demyelinating disorders where oligodendrocytes are the primary targets. We hypothesise that the ‘good’ or ‘bad’ aspects of Serpina3n/SERPINA3 depend on its cellular sources, its subcellular distribution (or mis‐localisation) and/or disease/injury types. Furthermore, circulating Serpina3n/SERPINA3 may cross the BBB to impact CNS pathologies. Cell‐specific genetic tools are critically important to tease out the potential roles of cell type‐dependent Serpina3n in CNS diseases/injuries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SerpinsHumansAnimalsCentral Nervous System DiseasesCentral Nervous SystemBlood-Brain Barrier

Stichwörter der Autor:innen

Serpina3n/SERPINA3blood–brain barriercell death/survivalmultiple sclerosismyelinneuroinflammationneurological disease/injuryneuron/glia

Substanzen

SERPINA3 protein, humanSerpins

Autor:innen und Institutionen

  • Department of Neurology, UC Davis School of Medicine, Institute for Pediatric Regenerative Medicine (IPRM), Shriners Hospitals for Children, Sacramento, California, USA.
  • Center for Brain Health and Brain Technology, Global Institute of Future Technology, Shanghai Jiao Tong University, Shanghai, China.
  • S.G. China Pharmaceutical University, Nanjing, China.

ORCID-Profile: Fuzheng Guo

Förderung

  • NINDS NIH HHS
  • National Institute of Neurological Disorders and Stroke
  • Shriners Hospitals for Children

Zitieren

APA

Zhu, M., Lan, Z., Park, J., Gong, S., Wang, Y., & Guo, F. (2024). Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles. Neuropathology and Applied Neurobiology, 50(2). https://doi.org/10.1111/nan.12980

Vancouver

Zhu M, Lan Z, Park J, Gong S, Wang Y, Guo F. Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles. Neuropathology and Applied Neurobiology. 2024;50(2). doi:10.1111/nan.12980

BibTeX
@article{Zhu2024,
  author = {Zhu, Meina and Lan, Zhaohui and Park, Joohyun and Gong, Shuaishuai and Wang, Yan and Guo, Fuzheng},
  title = {Regulation of CNS pathology by Serpina3n/SERPINA3: The knowns and the puzzles},
  journal = {Neuropathology and Applied Neurobiology},
  year = {2024},
  volume = {50},
  number = {2},
  doi = {10.1111/nan.12980}
}
Kostenlos starten →